Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatuline Autogel as primary medical treatment for acromegaly
2005-004300-36Phase 2Completed
- Sponsor
- NHS trust
- Start
- Sep 2005
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lanreotide in acromegaly, sponsored by NHS trust. Primary endpoint: Clinically significant change in tumour size at Month 12. Started Sep 2005; status: completed.
02
Drugs
lanreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on 2005-004300-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004300-36.